Business Context and Reporting Period
Company: Global Medical REIT Inc. (Note: Request metadata listed "Chiron Real Estate Inc.", but the filing identifies the registrant as Global Medical REIT Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: March 13, 2019
Event Date: March 12, 2019
Context: The Company entered into a Material Definitive Agreement to acquire a portfolio of inpatient rehabilitation facilities.
Key Financial Metrics and Transaction Details
- Transaction Type: Acquisition of four inpatient rehabilitation facilities (the "CNL Portfolio").
- Total Square Footage: 207,204 square feet.
- Aggregate Purchase Price: $94 million, subject to an additional $1 million earn-out payment.
- Allocated Price for Oklahoma City Property: $28 million (subject to Right of First Refusal).
- Aggregate Initial Annual Rent: Approximately $6.9 million.
- Weighted Average Remaining Initial Lease Term: Approximately 8.5 years.
- Earnest Money Deposit: $1.5 million (becomes non-refundable after March 15, 2019, unless terminated for cause).
Material Changes and Transaction Structure
The Company signed a purchase and sale agreement to acquire properties in Surprise, Arizona; Las Vegas, Nevada; Oklahoma City, Oklahoma; and Mishawaka, Indiana. The properties are leased to four tenants under triple-net leases:
- Las Vegas: Encompass Health (4 renewal options, 5-year terms).
- Surprise: Joint venture of Cobalt Rehabilitation and Tenet Healthcare (2 renewal options, 5-year terms).
- Oklahoma City: Joint venture of Mercy Health and Kindred Healthcare (3 renewal options, 10-year terms; includes tenant purchase option at Fair Market Value after 2027).
- Mishawaka: St. Joseph's Health System (2 renewal options, 5-year terms).
Guidance, Risks, and Contingencies
- Due Diligence Termination Right: The Company may terminate the agreement without penalty on or before March 15, 2019, if not satisfied with due diligence results.
- Right of First Refusal (ROFR): The Oklahoma City tenant has 30 days to exercise a ROFR. If exercised, the Company will not purchase that specific property, and the total purchase price will be reduced by $28 million.
- Closing Conditions: The acquisition is subject to customary terms and conditions. Management believes completion is probable but provides no assurance of a timely closing or closing at all.
- Financial Statements: This filing does not provide updated revenue, profit, cash flow, or debt metrics for the Company; it focuses solely on the acquisition agreement.
Investor Verification Checklist
- Verify the outcome of the due diligence period by March 15, 2019, to determine if the deal proceeds.
- Monitor the 30-day window for the Oklahoma City tenant's Right of First Refusal, which could reduce the deal size by $28 million.
- Confirm the final closing date and any adjustments to the $94 million purchase price.
- Review the full Purchase and Sale Agreement (Exhibit 10.1) when filed with the Form 10-Q for the quarter ended March 31, 2019.
- Assess the impact of the $1.5 million earnest money deposit on liquidity if the deal is terminated after the March 15 deadline.